Paul Haeder, Author

writing, interviews, editing, blogging

Patrick Duffy of ‘Dallas’ Fame Lists Oregon Ranch for $14 Million Imagine a world where smart cohesive thinkers come together and work with these multimillionaires and get some break on the property and then get a community going there: people who want to learn how to farm-raise animals; how to preserve foods; how to construct …

Continue reading

The level of censurous behavior, and the level of electronic cancellation, well, in this digital modern (sic) world, so-called Western Civilization has reached that inner fascist in all the country’s players. What, 73% in one poll (can’t trust those polls) say more money for UkriNaziLandia. Cognitive dissonance, and Kool-Aid Deluxe for the majority of Klanadians, …

Continue reading

Gulls Swooping in and Stealing Ice Cream for Makenna by Paul Haeder / September 11th, 2022 just read stories how gullsshape shift wingsanticipating bailing out, bombing inafter French fries on a pierbehind-the-back Dairy Queenthievery a child is like the shape shiftershe’s one person, one flightwing early in life, then wingschange for higher heights she’ll glide …

Continue reading

Amazing, really, all the money, all the human lifetimes wasted on the Morty ZioLensky’s most corrupt regime, all the oligarchs making money there, and of course, the endless gravy train for the most despicable of souls, those offensive murdering weapons manufacturers and the tens of thousands of other companies with big and little inside tracks …

Continue reading

I’ve written about this so much and have gotten students to research some of the direct and indirect topics tied to: Who are your masters, and how far will you go to get and keep a job? One solution for one issue — say, looking at crops and regulating soil wetness with a drone is …

Continue reading

It has been a good week for leading COVID-19 vaccine makers,  Pfizer PFE / BioNTech BNTX  and Moderna MRNA, with a string of positive news. The European Medicines Agency’s (“EMA”) Committee for Medicinal Products for Human Use (“CHMP”) has granted a positive opinion for a 30-µg booster dose of Pfizer’s/BioNTech’s Omicron BA.1 bivalent COVID-19 vaccine. CHMP recommended conditional marketing authorization …

Continue reading